Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech venture capital
Biotech
Bioluminescence enters biotech venture spotlight with $477M
Bioluminescence is jumping out of stealth with almost $500M in assets, including investments in ReCode and Nido.
Max Bayer
Nov 1, 2023 7:00am
Agomab uses $100M series C to push Crohn's drug through phase 2
Oct 11, 2023 8:50am
After pandemic sugar rush, biotechs eye stigmatized fundraisings
Oct 9, 2023 7:00am
Investors shower Star Therapeutics with $90M series C
Sep 5, 2023 7:00am
VC launches biotech fund with $450M and 'recipe for success'
Jul 17, 2023 12:26pm
New $50M VC fund to focus solely on blood and cell therapies
May 11, 2023 11:49am
